PROQR THERAPEUTICS NV (PRQR)
NL0010872495 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.4M -74.60% | 4.8M 100.00% | 9.525M 98.44% | 22.097M 131.99% | 20.096M -9.06% | 17.337M -13.73% | 14.69M -15.27% | 97.318M 562.48% | 94.722M -2.67% | 182.03M 92.17% | 274.23M 50.65% | |
| EBITDA YoY % growth | -54.86M -37.12% | -62.2M -13.38% | -29.346M 52.82% | -39.533M -34.71% | -22.918M 42.03% | -51.818M -126.10% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.19M -34.98% | -64.72M -13.17% | -31.859M 50.77% | -39.422M -23.74% | -28.208M 28.45% | -52.707M -86.85% | -71.41M -35.48% | -2.963M 95.85% | -22.817M -670.06% | 45.912M 301.22% | 117.95M 156.90% | |
| Operating Margin | -2,382.92% | -1,348.33% | -334.48% | -178.41% | -140.37% | -304.01% | -486.11% | -3.04% | -24.09% | 25.22% | 43.01% | |
| EPS YoY % growth | -0.97 -5.43% | -0.91 6.19% | -0.35 61.54% | -0.31 10.29% | -0.42 -32.47% | -0.53 -28.14% | N/A | N/A | N/A | N/A | N/A |
All data in EUR
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 -17.08% | -0.05 49.00% | -0.05 -70.00% | -0.06 38.80% | -0.09 -5.79% | -0.19 -307.42% | -0.18 -246.22% | -0.17 -185.40% | -0.17 -93.80% |
| Revenue Q2Q % growth | 8.378M 34.80% | 8.59M 93.03% | 8.59M 36.24% | 8.539M 122.20% | 6.652M -20.60% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -12.966M -245.31% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.591M -100.87% | -3.926M 51.38% | -4.665M -29.60% | -5.442M 37.57% | -6.257M 50.31% | N/A | N/A | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.10 -42.86% | -0.11 | 0.01 | 7.09% |
| Q2 2024 Q2Q % growth | -0.03 70.00% | -0.13 | 0.10 | 76.42% |
| Q1 2024 Q2Q % growth | -0.09 18.18% | -0.11 | 0.02 | 19.45% |
| Q4 2023 Q2Q % growth | -0.07 56.25% | 0.01 | -0.08 | -732.51% |
| Q3 2023 Q2Q % growth | -0.07 79.41% | -0.09 | 0.02 | 19.37% |
| Q2 2023 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 11.76% |
| Q1 2023 Q2Q % growth | -0.11 45.00% | -0.12 | 0.01 | 8.34% |
| Q4 2022 Q2Q % growth | -0.16 38.46% | -0.18 | 0.02 | 12.13% |
| Q3 2022 Q2Q % growth | -0.34 -54.55% | -0.21 | -0.13 | -58.31% |
| Q2 2022 Q2Q % growth | -0.21 12.50% | -0.22 | 0.01 | 4.64% |
| Q1 2022 Q2Q % growth | -0.20 20.00% | -0.24 | 0.04 | 16.75% |
| Q4 2021 Q2Q % growth | -0.26 | -0.19 | -0.07 | -37.23% |
| Q3 2021 Q2Q % growth | -0.22 15.38% | -0.21 | -0.01 | -5.20% |
| Q2 2021 Q2Q % growth | -0.24 -200.00% | -0.24 | 0.00 | 0.80% |
| Q1 2021 Q2Q % growth | -0.25 21.88% | -0.25 | 0.00 | 1.84% |
| Q4 2020 Q2Q % growth | -0.26 33.33% | -0.26 | 0.00 | -1.57% |
| Q3 2020 Q2Q % growth | -0.26 16.13% | -0.31 | 0.05 | 15.21% |
| Q2 2020 Q2Q % growth | -0.08 75.00% | -0.33 | 0.25 | 76.06% |
| Q1 2020 Q2Q % growth | -0.32 11.15% | -0.35 | 0.03 | 8.27% |
| Q4 2019 Q2Q % growth | -0.39 | -0.36 | -0.03 | -8.47% |
| Q3 2019 Q2Q % growth | -0.31 | -0.35 | 0.04 | 11.62% |
| Q2 2019 Q2Q % growth | -0.32 | -0.39 | 0.07 | 18.12% |
| Q1 2019 Q2Q % growth | -0.36 | -0.37 | 0.01 | 3.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.843M 180.51% | 11.296M | -7.453M | -65.98% |
| Q2 2024 Q2Q % growth | 6.305M 407.65% | 11.685M | -5.38M | -46.04% |
| Q1 2024 Q2Q % growth | 4.45M 579.39% | 3.2M | 1.25M | 39.06% |
| Q4 2023 Q2Q % growth | 6.215M 374.43% | 15.027M | -8.812M | -58.64% |
| Q3 2023 Q2Q % growth | 1.37M 53.93% | 3.383M | -2.013M | -59.50% |
| Q2 2023 Q2Q % growth | 1.242M 20.58% | 1.242M | 0.00% | |
| Q1 2023 Q2Q % growth | 655K -46.75% | 1.341M | -686K | -51.16% |
| Q4 2022 Q2Q % growth | 1.31M 197.73% | 975.446K | 334.554K | 34.30% |
| Q3 2022 Q2Q % growth | 890K -23.28% | 855.77K | 34.23K | 4.00% |
| Q2 2022 Q2Q % growth | 1.03M 58.46% | 731.728K | 298.272K | 40.76% |
| Q1 2022 Q2Q % growth | 1.23M 778.57% | 553.615K | 676.385K | 122.18% |
| Q4 2021 Q2Q % growth | 440K 69.23% | 402.084K | 37.916K | 9.43% |
| Q3 2021 Q2Q % growth | 1.16M 364.00% | 236.181K | 923.819K | 391.15% |
| Q2 2021 Q2Q % growth | 650K -92.50% | 195.381K | 454.619K | 232.68% |
| Q1 2021 Q2Q % growth | 140K -46.15% | 463.304K | -323.304K | -69.78% |
| Q4 2020 Q2Q % growth | 260K -38.10% | 191.944K | 68.056K | 35.46% |
| Q3 2020 Q2Q % growth | 250K -52.83% | 141.413K | 108.587K | 76.79% |
| Q2 2020 Q2Q % growth | 8.67M 1,448.21% | 426.044K | 8.244M | 1,935.00% |
| Q1 2020 Q2Q % growth | 260K -38.10% | 426.044K | -166.044K | -38.97% |
| Q4 2019 Q2Q % growth | 420K | 547.791K | -127.791K | -23.33% |
| Q3 2019 Q2Q % growth | 530K | 802.975K | -272.975K | -34.00% |
| Q2 2019 Q2Q % growth | 560K | 488.968K | 71.032K | 14.53% |
| Q1 2019 Q2Q % growth | 420K | 642.753K | -222.753K | -34.66% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 23.53% | -7.36% | -1.14% |
| Revenue | 0% | 55.06% | -28.75% | -17.37% |